L-R Shripad Desai, DSVP & Country Team Liaison, Americares, Brig (Dr) K Venkatnarayan, Officer on Special Duty (Health), NITI Aayog,Meenakshi Nevatia, MD, Pfizer Ltd., Dr. Vijay Agarwal, President, CAHO
Pfizer and Americares India Foundation (AIF) today proudly announced the remarkable success of Project Parivartan—a collaborative initiative to combat Antimicrobial Resistance (AMR) in India, with its 11 participating hospitals across 7 states scoring an average of 90% across Infection Prevention and Control (IPC) and Antimicrobial Stewardship (AMS), in the National Accreditation Board for Hospitals & Healthcare Providers (NABH) audit. The project aimed at demonstrating reduction in infections and in prevalence of multi-drug resistant organisms in small to mid-sized hospitals through infection prevention and control and antimicrobial stewardship activities.
To provide a blueprint to similar hospitals and institutions across the country, learnings and accomplishments of the project were also unveiled in a report titled Project Parivartan: Insights and learnings from an evidence-based approach to combat AMR. The report, aimed at providing credible information and inspiration to healthcare providers and hospitals, will be published in detail in leading scientific journals and is poised to help caregivers implement best-in-class AMS practices for better patient outcomes.
Among the various outcomes achieved through this program, notable ones include:
1. Reduction in Infections: An average 30% reduction in hospital-acquired infections across all 11 participating hospitals, showcasing effective strategies that yielded positive results in addressing AMR.
2. Decrease in Multidrug-Resistant Organisms: Demonstrated a substantial 24.2% reduction in the rate of multidrug-resistant organisms, indicating a rigor on both IPC and AMS practices.
3. Knowledge Gain among Healthcare Workers: Post-intervention, healthcare workers showed an average knowledge gain of 95% in Antimicrobial Stewardship (AMS) and 88% in Infection Prevention and Control (IPC).
4. Compliance: Achieved an average compliance rate of 85% in critical areas such as hand hygiene, IPC care bundles, and antibiotic policy.
The project outcomes and report were released at an event titled “Uniting Against Antimicrobial Resistance” that saw participation from distinguished speakers and panellists, including Dr. Narendra Saini, Chairman IMA AMR Standing Committee, and Dr. Sanjeev Singh, Medical Director at Amrita Institute of Medical Sciences, Faridabad. Focused on sustainable strategies in the fight against AMR, the event highlighted valuable perspectives and achievements of Project Parivartan including its partner hospitals. Panel discussions, such as “Navigating the AMR Landscape” and “Perspectives on Antimicrobial Stewardship,” encouraged the need for broader awareness and collaboration for a resilient future in combating AMR.
Meenakshi Nevatia, Managing Director of Pfizer India, stated, “Project Parivartan stands as a testament to our unwavering commitment to tackling our country’s primary health crises in partnership with our hospitals and our healthcare professionals. Through our years of collaboration with Americares India Foundation, we have driven real change in combating AMR and elevating healthcare standards across our country’s health ecosystem. With the 11 hospitals that have transformed themselves, we have taken the first few steps. We hope this report will inspire hospitals across the country to take the necessary steps to tackle the challenge of AMR.”
Shripad Desai, Deputy Senior Vice President, Country Team Liaison, said, “Project Parivartan’s success marks a significant milestone in our fight against Antimicrobial Resistance. Through collaboration with Pfizer, we’ve achieved tangible results, emphasizing the importance of collective action in healthcare. We extend our gratitude to all contributors and stress the need for ongoing collaboration to address global health challenges effectively.”
At the event, in response to these achievements, Pfizer, and Americares India Foundation called for sustained action, emphasizing the crucial need for collaboration among clinicians, researchers, policymakers, and corporate entities to maintain the momentum in the fight against AMR.
Disclaimer: This media release is auto-generated. The CSR Journal is not responsible for the content.
